MSTN and cirrhosis of liver: Nishikawa et al. [67] have demonstrated that higher levels of myostatin is associated with hyperammonemia and muscle loss in cirrhotic patients; moreover, patients with increased myostatin had worse prognosis, suggesting the importance of muscle in the prognostic overview of the patient with liver cirrhosis.